Kathleen A. Rickard

Insider Reports History

Location
London, United Kingdom
Signature
/s/ Andrew Fisher, Attorney-in-fact for Kathleen A. Rickard
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kathleen A. Rickard:

Company Role Class Num Shares Value Price $ Report Date Ownership
Verona Pharma plc Chief Medical Officer Ordinary Shares 0 $0 $106.71 07 Oct 2025 Direct
Verona Pharma plc Chief Medical Officer Restricted Share Units 167,056 07 Jul 2025 Direct
Verona Pharma plc Chief Medical Officer Restricted Stock Units 146,168 01 Aug 2025 Direct
Verona Pharma plc Chief Medical Officer Restricted Share Unit 0 07 Oct 2025 Direct
Verona Pharma plc Chief Medical Officer Share Options (Right to Buy) 0 07 Oct 2025 Direct

Insider Reports Filed by Kathleen A. Rickard

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VRNA Verona Pharma plc 07 Oct 2025 10 $0 4 Chief Medical Officer 08 Oct 2025, 16:43
VRNA Verona Pharma plc 29 Aug 2025 1 $0 4 Chief Medical Officer 03 Sep 2025, 16:30
VRNA Verona Pharma plc 01 Aug 2025 4 -$766,751 4 Chief Medical Officer 05 Aug 2025, 20:27
VRNA Verona Pharma plc 07 Jul 2025 4 -$430,376 4 Chief Medical Officer 09 Jul 2025, 18:39
VRNA Verona Pharma plc 06 May 2025 1 -$1,014,343 4 Chief Medical Officer 08 May 2025, 16:30
VRNA Verona Pharma plc 01 May 2025 4 -$440,350 4 Chief Medical Officer 05 May 2025, 16:32
VRNA Verona Pharma plc 12 Mar 2025 1 -$661,942 4 Chief Medical Officer 13 Mar 2025, 20:15
VRNA Verona Pharma plc 01 Feb 2025 2 -$238,082 4 Chief Medical Officer 04 Feb 2025, 16:30
VRNA Verona Pharma plc 25 Nov 2024 1 -$1,176,360 4 Chief Medical Officer 26 Nov 2024, 18:34
VRNA Verona Pharma plc 30 Oct 2024 3 -$279,648 4 Chief Medical Officer 01 Nov 2024, 19:17
VRNA Verona Pharma plc 07 Aug 2024 5 -$308,768 4 Chief Medical Officer 01 May 2025, 20:56
VRNA Verona Pharma plc 07 Aug 2024 2 -$230,308 4 Chief Medical Officer 09 Aug 2024, 19:12
VRNA Verona Pharma plc 01 Aug 2024 1 -$300,902 4 Chief Medical Officer 05 Aug 2024, 21:28
VRNA Verona Pharma plc 01 May 2024 2 -$213,608 4 Chief Medical Officer 03 May 2024, 19:21
VRNA Verona Pharma plc 01 Feb 2024 2 -$247,418 4 Chief Medical Officer 05 Feb 2024, 18:11
VRNA Verona Pharma plc 01 Nov 2023 2 -$414,718 4 Chief Medical Officer 03 Nov 2023, 20:11
VRNA Verona Pharma plc 20 Oct 2023 1 $0 4 Chief Medical Officer 24 Oct 2023, 16:06
VRNA Verona Pharma plc 03 Aug 2023 4 -$202,576 4 Chief Medical Officer 07 Aug 2023, 21:19
VRNA Verona Pharma plc 01 Aug 2023 2 -$88,469 4 Chief Medical Officer 03 Aug 2023, 20:27
VRNA Verona Pharma plc 01 May 2023 2 $0 4/A Chief Medical Officer 11 May 2023, 16:15
VRNA Verona Pharma plc 20 Jan 2023 4 -$302,731 4 Chief Medical Officer 03 Feb 2023, 17:17
VRNA Verona Pharma plc 01 Nov 2022 2 -$137,147 4 Chief Medical Officer 03 Nov 2022, 16:05
VRNA Verona Pharma plc 26 Sep 2022 1 $0 4 Chief Medical Officer 28 Sep 2022, 16:07
VRNA Verona Pharma plc 01 Aug 2022 2 -$58,166 4 Chief Medical Officer 03 Aug 2022, 16:11
VRNA Verona Pharma plc 03 May 2022 1 -$14,155 4 Chief Medical Officer 05 May 2022, 19:19
VRNA Verona Pharma plc 01 May 2022 1 -$29,486 4 Chief Medical Officer 03 May 2022, 20:20
VRNA Verona Pharma plc 08 Apr 2022 2 -$98,482 4 Chief Medical Officer 12 Apr 2022, 16:05
VRNA Verona Pharma plc 01 Feb 2022 1 -$49,335 4 Chief Medical Officer 03 Feb 2022, 16:57
VRNA Verona Pharma plc 01 Nov 2021 1 -$36,434 4 Chief Medical Officer 03 Nov 2021, 19:53
VRNA Verona Pharma plc 01 Aug 2021 1 -$178,773 4 Chief Medical Officer 03 Aug 2021, 22:00